NYXOAH SA - ORDINARY S

Nyxoah BETTER SLEEP Trial Reaches its Primary Endpoints

07 6 2021 01:00:00 提供 Nasdaq GlobeNewswire

Publication relating to a transparency notification

26 5 2021 13:25:33 提供 Nasdaq GlobeNewswire

Invitation to attend the annual shareholders’ meeting of the Company to be held on 9 June 2021

07 5 2021 01:00:00 提供 Nasdaq GlobeNewswire

Nyxoah Announces Submission of Draft Registration Statement For Proposed Public Listing in the United States

19 4 2021 01:02:35 提供 Nasdaq GlobeNewswire

Nyxoah Reports Full Year 2020 Results

09 4 2021 00:57:16 提供 Nasdaq GlobeNewswire

Nyxoah to Delay Full Year 2020 Earnings Release Until April 9, 2021  

02 4 2021 01:02:48 提供 Nasdaq GlobeNewswire

Nyxoah announces the publication of first positive clinical data in an OSA patient suffering from Complete Concentric Collapse (CCC)

03 3 2021 00:58:24 提供 Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

25 2 2021 12:00:28 提供 Nasdaq GlobeNewswire

Nyxoah to present at the Oppenheimer 31st Annual Healthcare Conference

24 2 2021 01:01:35 提供 Nasdaq GlobeNewswire

Nyxoah receives FDA approval for full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)

09 2 2021 01:00:13 提供 Nasdaq GlobeNewswire

Nyxoah and Vanderbilt University enter exclusive licensing agreement regarding next generation neurostimulation technologies to treat Obstructive Sleep Apnea (OSA)

02 2 2021 00:56:05 提供 Nasdaq GlobeNewswire

Nyxoah announces full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)

26 1 2021 01:02:09 提供 Nasdaq GlobeNewswire

First US patient implanted in the DREAM pivotal IDE study, with the Genio® system for the treatment of Obstructive Sleep Apnea (OSA)

05 1 2021 01:39:42 提供 Nasdaq GlobeNewswire